Database of Health Workforce Innovations
582
Telemedicine for Diabetes Care in India
COVID-19 Pandemic related travel restrictions make face-to-face visits and consultations difficult for diabetic patients, which can lead to poor glycemic control and worsening of complications and co-morbid conditions.
Telemedicine is proposed for continued management of diabetic patients during the lockdown.
- Telehealth/virtual care
- IT/infrastructure for virtual care
- Other
- Physicians - Specialists
India, like countries around the world, has been affected by the novel coronavirus. A 21 day national lockdown was enacted to limit the spread of the disease.
Diabetes has been identified as being a major risk factor for complications and death due to COVID-19.
Diabetes has been identified as being a major risk factor for complications and death due to COVID-19.
- Other
Existing regulations allow state registered medical practitioners to practice telemedicine in India.
Research Intervention - outcome data available
Ghosh, A., Gupta, R., & Misra, A. (2020). Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: guidelines for physicians. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 14(4), 273-6.
Anoop Misra
Fortis CDOC Hospital for Diabetes and Allied Specialties
Asia
India